PharmaCorp Announces CFO Transition and Appointment of Andrew Hodson as Chief Financial Officer
New CFO Andrew Hodson brings to PharmaCorp more than 11 years of financial leadership, including capital markets experience and over six years leading global finance teams in high-growth and acquisition-driven businesses SASKATOON, Saskatchewan, Oct. 14, 2026 (GLOBE NEWSWIRE) — PHARMACORP RX INC. (“PharmaCorp” or the “Corporation”) (TSXV: PCRX), a Canadian pharmacy acquisition and ownership…
Read original article on Financial Post →Related news
-
3rd member of Canadian Armed Forces charged in kidnapping probe: Toronto police
-
Children, 11 and 9, steal parents’ car for early morning joyride: OPP
- Canada’s top banking regulator wants to address competitive imbalance between small and large banks
- Ontario announces permanent daylight saving time for northwestern parts of the province
-
Travail en présentiel | 87 % des professionnels de la fonction publique n’y voient pas de gain, selon le syndicat
-
Houthis strike Saudi oil company Aramco’s headquarters, officials say
-
Phantom hijack scare forces emergency landing of Air India jet
- Sirion and Legora partner to bring agentic legal AI and enterprise contract intelligence together in one connected experience